Matches in SemOpenAlex for { <https://semopenalex.org/work/W3166795716> ?p ?o ?g. }
- W3166795716 abstract "Abstract Background Low-risk human papillomavirus (HPV), such as types 6 and 11, is considered non-oncogenic, but these types have been detected in oral cancer tissue samples, suggesting their possible involvement in oral carcinogenesis. Because double infection of high-risk HPV and Epstein-Barr virus (EBV) is known to be involved in oral carcinogenesis, we hypothesized that low-risk HPV and EBV co-infection can transform the oral cells. To verify our hypothesis, we evaluated the transformation activity of cell lines expressing both low-risk HPV E6/E7 and EBV LMP-1. Methods We transduced HPV6, 11 and 16 E6/E7 genes and EBV LMP-1 gene into primary mouse embryonic fibroblasts. The cell lines were examined for indices of transformation activity such as proliferation, induction of DNA damage, resistance to apoptosis, anchorage-independent growth, and tumor formation in nude mice. To evaluate the signaling pathways involved in transformation, NF-κB and p53 activities were analyzed. We also assessed adhesion signaling molecules associated with anchorage-independent growth such as MMP-2, paxillin and Cat-1. Results Co-expression of low-risk HPV6 E6 and EBV LMP-1 showed increased cell proliferation, elevated NF-κB activity and reduced p53 induction. Moreover, co-expression of low-risk HPV6 E6 and EBV LMP-1 induced DNA damage, escaped from apoptosis under genotoxic condition and suppression of DNA damage response (DDR). Co-expression of low-risk HPV11 E6/E7 and EBV LMP-1 demonstrated similar results. However, it led to no malignant characteristics such as anchorage-independent growth, invasiveness and tumor formation in nude mice. Compared with the cells co-expressing high-risk HPV16 E6 and EBV LMP-1 that induce transformation, co-expression of low-risk HPV6 E6 and EBV LMP-1 was associated with low MMP-2, paxillin and Cat-1 expression. Conclusions The co-expression of low-risk HPV E6/E7 and EBV LMP-1 does not induce malignant transformation, but it allows accumulation of somatic mutations secondary to increased DNA damage and suppression of DDR. Thus, double infection of low-risk HPV and EBV could lead to precancerous lesions." @default.
- W3166795716 created "2021-06-22" @default.
- W3166795716 creator A5003220744 @default.
- W3166795716 creator A5030929680 @default.
- W3166795716 creator A5031423155 @default.
- W3166795716 creator A5033625421 @default.
- W3166795716 creator A5038701551 @default.
- W3166795716 creator A5045867803 @default.
- W3166795716 creator A5046682153 @default.
- W3166795716 creator A5056759646 @default.
- W3166795716 creator A5070507396 @default.
- W3166795716 creator A5089457652 @default.
- W3166795716 date "2021-06-10" @default.
- W3166795716 modified "2023-10-13" @default.
- W3166795716 title "Co-expression of low-risk HPV E6/E7 and EBV LMP-1 leads to precancerous lesions by DNA damage" @default.
- W3166795716 cites W1488252042 @default.
- W3166795716 cites W1620032110 @default.
- W3166795716 cites W190015672 @default.
- W3166795716 cites W1965127442 @default.
- W3166795716 cites W1971660947 @default.
- W3166795716 cites W1971749273 @default.
- W3166795716 cites W1978032326 @default.
- W3166795716 cites W1983167174 @default.
- W3166795716 cites W1991180306 @default.
- W3166795716 cites W2014140505 @default.
- W3166795716 cites W2021564843 @default.
- W3166795716 cites W2024087409 @default.
- W3166795716 cites W2040367702 @default.
- W3166795716 cites W2041544310 @default.
- W3166795716 cites W2052018833 @default.
- W3166795716 cites W2065678982 @default.
- W3166795716 cites W2066158249 @default.
- W3166795716 cites W2068965703 @default.
- W3166795716 cites W2075222638 @default.
- W3166795716 cites W2093629370 @default.
- W3166795716 cites W2095024877 @default.
- W3166795716 cites W2101196984 @default.
- W3166795716 cites W2114890741 @default.
- W3166795716 cites W2117692326 @default.
- W3166795716 cites W2118441422 @default.
- W3166795716 cites W2121432461 @default.
- W3166795716 cites W2138241311 @default.
- W3166795716 cites W2165042359 @default.
- W3166795716 cites W2166907736 @default.
- W3166795716 cites W2185988458 @default.
- W3166795716 cites W2575375621 @default.
- W3166795716 cites W2941692218 @default.
- W3166795716 doi "https://doi.org/10.1186/s12885-021-08397-0" @default.
- W3166795716 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8194219" @default.
- W3166795716 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34112111" @default.
- W3166795716 hasPublicationYear "2021" @default.
- W3166795716 type Work @default.
- W3166795716 sameAs 3166795716 @default.
- W3166795716 citedByCount "6" @default.
- W3166795716 countsByYear W31667957162021 @default.
- W3166795716 countsByYear W31667957162022 @default.
- W3166795716 countsByYear W31667957162023 @default.
- W3166795716 crossrefType "journal-article" @default.
- W3166795716 hasAuthorship W3166795716A5003220744 @default.
- W3166795716 hasAuthorship W3166795716A5030929680 @default.
- W3166795716 hasAuthorship W3166795716A5031423155 @default.
- W3166795716 hasAuthorship W3166795716A5033625421 @default.
- W3166795716 hasAuthorship W3166795716A5038701551 @default.
- W3166795716 hasAuthorship W3166795716A5045867803 @default.
- W3166795716 hasAuthorship W3166795716A5046682153 @default.
- W3166795716 hasAuthorship W3166795716A5056759646 @default.
- W3166795716 hasAuthorship W3166795716A5070507396 @default.
- W3166795716 hasAuthorship W3166795716A5089457652 @default.
- W3166795716 hasBestOaLocation W31667957161 @default.
- W3166795716 hasConcept C104317684 @default.
- W3166795716 hasConcept C121608353 @default.
- W3166795716 hasConcept C134935766 @default.
- W3166795716 hasConcept C143425029 @default.
- W3166795716 hasConcept C190283241 @default.
- W3166795716 hasConcept C203014093 @default.
- W3166795716 hasConcept C31033888 @default.
- W3166795716 hasConcept C502942594 @default.
- W3166795716 hasConcept C54355233 @default.
- W3166795716 hasConcept C552990157 @default.
- W3166795716 hasConcept C555283112 @default.
- W3166795716 hasConcept C62112901 @default.
- W3166795716 hasConcept C86803240 @default.
- W3166795716 hasConceptScore W3166795716C104317684 @default.
- W3166795716 hasConceptScore W3166795716C121608353 @default.
- W3166795716 hasConceptScore W3166795716C134935766 @default.
- W3166795716 hasConceptScore W3166795716C143425029 @default.
- W3166795716 hasConceptScore W3166795716C190283241 @default.
- W3166795716 hasConceptScore W3166795716C203014093 @default.
- W3166795716 hasConceptScore W3166795716C31033888 @default.
- W3166795716 hasConceptScore W3166795716C502942594 @default.
- W3166795716 hasConceptScore W3166795716C54355233 @default.
- W3166795716 hasConceptScore W3166795716C552990157 @default.
- W3166795716 hasConceptScore W3166795716C555283112 @default.
- W3166795716 hasConceptScore W3166795716C62112901 @default.
- W3166795716 hasConceptScore W3166795716C86803240 @default.
- W3166795716 hasFunder F4320334764 @default.
- W3166795716 hasIssue "1" @default.
- W3166795716 hasLocation W31667957161 @default.
- W3166795716 hasLocation W31667957162 @default.
- W3166795716 hasLocation W31667957163 @default.